Malvern, PA, United States of America

Thomas R Gervais

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2014.


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Thomas R Gervais

Introduction

Thomas R Gervais is an accomplished inventor based in Malvern, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of antibody production. His innovative work has led to the development of methods that enhance the purification of antibody Fc domains.

Latest Patents

Gervais holds a patent for a process titled "Process for preparing unaggregated antibody Fc domains." This patent describes methods useful for producing a solution of purified Fc peptide chains. The methods employ protein A chromatography to effectively separate high molecular weight, aggregated peptide chains from lower molecular weight unaggregated peptide chains. The solutions obtained through these methods contain less than 5% aggregate and greater than 70% of the Fc peptide chains subjected to purification.

Career Highlights

Gervais is currently associated with Janssen Biotech, Inc., where he continues to advance his research and development efforts. His work has been instrumental in improving the efficiency of antibody production processes, which is crucial for therapeutic applications.

Collaborations

Some of his notable coworkers include Pedro Alfonso and Michael Capaldi. Their collaborative efforts contribute to the innovative environment at Janssen Biotech, Inc.

Conclusion

Thomas R Gervais is a notable inventor whose work in antibody purification has the potential to significantly impact the biotechnology industry. His contributions reflect a commitment to advancing scientific knowledge and improving therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…